[Immunopathogenesis of inflammatory bowel diseases: new approaches for therapy?].
Beglinger
C
C
Abteilung für Gastroenterologie, Kantonsspital, Basel.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000942:Antigens, Bacterial / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D018836:Inflammation Mediators / Q000378:metabolism; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy / Q000276:immunology*; D007413:Intestinal Mucosa / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects / Q000276:immunology; D018089:Superantigens / Q000276:immunology
D000900:Anti-Bacterial Agents; D000942:Antigens, Bacterial; D007166:Immunosuppressive Agents; D018836:Inflammation Mediators; D018089:Superantigens
Immunpathogenese von entzündlichen Darmerkrankungen: neue Ansätze für die Therapie?